Amarin (AMRN) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Vogenx is the larger company by market cap ($253.1 million vs $252.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AMRN | VOGX |
|---|---|---|
| Share price | $11.95 | $17.04 |
| Market cap | $252.42M | $253.13M |
| 1-day change | -0.58% | +5.45% |
| YTD return | -13.90% | — |
| 1-year return | -37.62% | — |
| 5-year return | -88.35% | — |
| Forward P/E | 12.19 | — |
| EPS (TTM) | $-1.20 | $-0.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $20.90 | $38.41 |
| 52-week low | $11.83 | $12.95 |
| Distance from 52-week high | -42.82% | -55.64% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +4.60% | +222.77% |
| Average volume | 66.16K | 188.79K |
| Shares outstanding | 21.12M | 14.86M |
| Employees | 80 | 4 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Amarin
AMRN stock →Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia.
Health Care · Biotechnology: Pharmaceutical Preparations · 80 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
AMRN vs VOGX FAQ
Which is bigger, Amarin or Vogenx?
Vogenx (VOGX) is larger, with a market capitalization of $253.13M compared with $252.42M for Amarin (AMRN).
Are Amarin and Vogenx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.